[1]刘 鹏,陈 阵.微小RNA-19a-3p对充血性心力衰竭模型大鼠心肌纤维化的影响及机制研究[J].陕西医学杂志,2023,52(9):1125-1129,1134.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.003]
 LIU Peng,CHEN Zhen.Effect and mechanism of microRNA-19a-3p on myocardial fibrosis in rats with congestive heart failure[J].,2023,52(9):1125-1129,1134.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.003]
点击复制

微小RNA-19a-3p对充血性心力衰竭模型大鼠心肌纤维化的影响及机制研究
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年9期
页码:
1125-1129,1134
栏目:
基础研究
出版日期:
2023-09-05

文章信息/Info

Title:
Effect and mechanism of microRNA-19a-3p on myocardial fibrosis in rats with congestive heart failure
作者:
刘 鹏陈 阵
(武汉市中医医院心内科,湖北 武汉 430010)
Author(s):
LIU PengCHEN Zhen
(Department of Cardiology,Wuhan Hospital of Traditional Chinese Medicine,Wuhan 430010,China)
关键词:
充血性心力衰竭 大鼠 微小RNA-19a-3p 腺苷酸活化蛋白激酶 沉默信息调节因子1 过氧化物酶体增殖物激活受体γ辅激活因子1α 心肌纤维化
Keywords:
Congestive heart failure Rats miR-19a-3p Adenosine monophosphate-activated protein kinase Silencing information regulator 1 Peroxisome proliferator-activated receptor γ-coactivator 1α Myocardial fibrosis
分类号:
R 541.61
DOI:
DOI:10.3969/j.issn.1000-7377.2023.09.003
文献标志码:
A
摘要:
目的:探讨微小RNA-19a-3p(miR-19a-3p)对充血性心力衰竭(CHF)模型大鼠心肌纤维化的影响及机制。方法:将60只SD大鼠随机分为NC组、Model组、NC agomir组(尾静脉注射NC agomir)、miR-19a-3p agomir组(尾静脉注射miR-19a-3p agomir)、miR-19a-3p agomir+腺苷酸活化蛋白激酶(AMPK)抑制剂Compound C组(尾静脉注射miR-19a-3p agomir和250 μg/kg Compound C),每组12只。NC组仅暴露腹主动脉而不结扎,其他组均构建CHF模型。给药结束后,比较各组大鼠血流动力学参数[左心室收缩压(LVSP)、左心室内压最大上升速率(+dp/dtmax)]和心脏功能指标[左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)、室间隔厚度(IVS)、左心室功能(LVEF)]。Masson染色检测心肌纤维化情况。Western blot检测大鼠心肌组织Ⅰ型胶原蛋白(Collagen Ⅰ)、Ⅲ型胶原蛋白(Collagen Ⅲ)、转化生长因子-β(TGF-β)及通过调控AMPK/沉默信息调节因子1(SIRT1)/过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC-1α)通路相关蛋白表达。实时荧光定量聚合酶链反应(RT-qPCR)检测大鼠心肌组织miR-19a-3p的相对表达量。结果:与NC组比较,Model组大鼠心肌纤维化程度加重,LVSP、+dp/dtmax、LVEF、miR-19a-3p表达水平及p-AMPK/AMPK、SIRT1、PGC-1α蛋白表达降低,LVESD、LVEDD、IVS及Collagen Ⅰ、Collagen Ⅲ、TGF-β蛋白表达升高(均P<0.05)。与Model组、NC agomir组比较,miR-19a-3p agomir组大鼠心肌纤维化程度改善,LVSP、+dp/dtmax、LVEF、miR-19a-3p表达水平及p-AMPK/AMPK、SIRT1、PGC-1α蛋白表达升高,LVESD、LVEDD、IVS及Collagen Ⅰ、Collagen Ⅲ、TGF-β蛋白表达降低(均P<0.05)。与miR-19a-3p agomir组比较,miR-19a-3p agomir+Compound C组大鼠心肌纤维化程度加重,LVSP、+dp/dtmax、LVEF及p-AMPK/AMPK、SIRT1、PGC-1α蛋白表达降低,LVESD、LVEDD、IVS及Collagen Ⅰ、Collagen Ⅲ、TGF-β蛋白表达升高(均P<0.05),而miR-19a-3p表达水平比较差异无统计学意义(P>0.05)。结论:过表达miR-19a-3p可能通过激活AMPK/SIRT1/PGC-1α通路抑制CHF大鼠心肌纤维化。
Abstract:
Objective:To explore the effect and mechanism of microRNA-19a-3p(miR-19a-3p)on myocardial fibrosis in rats with congestive heart failure(CHF).Methods:Sixty SD rats were randomly divided into NC group,Model group,NC agomir group(tail vein injection of NC agomir),miR-19a-3p agomir group(tail vein injection of miR-19a-3p agomir),miR-19a-3p agomir+Compound C(AMPK inhibitor)group(tail vein injection of miR-19a-3p agomir and 250 μg/kg Compound C),with 12 rats in each group.In the NC group,only the abdominal aorta was exposed without ligation,and the CHF model was constructed in the form of abdominal aortic stenosis in the other groups.After the administration,the hemodynamic parameters LVSP and +dp/dtmax)and cardiac function indexes(LVEDD,LVESD,IVS and LVEF)were compared in each group.Masson staining was used to detect myocardial fibrosis.Western blot was used to detect the expression of Collagen Ⅰ,Collagen Ⅲ,TGF-β and AMPK/SIRT1/PGC-1α pathway related proteins in rat myocardial tissue.RT-qPCR was used to detect miR-19a-3p expression in rat myocardial tissue.Results:Compared with the NC group,the degree of myocardial fibrosis in the Model group increased,the LVSP,+dp/dtmax,LVEF,the expression level of miR-19a-3p,and the protein expressions of p-AMPK/AMPK,SIRT1 and PGC-1α were significantly reduced,the LVEDD,LVESD,IVS,and Collagen Ⅰ,Collagen Ⅲ,and TGF-β protein expressions were significantly increased(all P<0.05).Compared with the Model group and the NC agomir group,the degree of myocardial fibrosis in the miR-19a-3p agomir group was weakened,the LVSP,+dp/dtmax,LVEF,the expression level of miR-19a-3p,and the protein expressions of p-AMPK/AMPK,SIRT1 and PGC-1α were significantly increased,the LVESD,LVEDD,IVS,and the protein expressions of Collagen Ⅰ,Collagen Ⅲ and TGF-β were significantly reduced(all P<0.05).Compared with the miR-19a-3p agomir group,the degree of myocardial fibrosis in the miR-19a-3p agomir+Compound C group was enhanced,the LVSP,+dp/dtmax,LVEF,and the protein expressions of p-AMPK/AMPK,SIRT1 and PGC-1α were significantly reduced,the LVESD,LVEDD,IVS,and the protein expressions of Collagen Ⅰ,Collagen Ⅲ and TGF-β were significantly increased(all P<0.05),and there was no significant difference in the expression level of miR-19a-3p(P>0.05).Conclusion:Overexpression of miR-19a-3p may inhibit myocardial fibrosis in CHF rats by activating AMPK/SIRT1/PGC-1α pathway.

参考文献/References:

[1] 韩 媛,曾新春.半乳糖凝集素-3抑制剂柑橘果胶对心力衰竭大鼠血浆N端B型利钠肽原及心肌纤维化的影响[J].陕西医学杂志,2021,51(6):680-683,705.
[2] 唐诗倩,陆士娟,马添翼,等.miRNA-1对慢性充血性心力衰竭小鼠左心室心肌Cx43蛋白表达的影响[J].沈阳药科大学学报,2021,38(7):706-713.
[3] Jonesbuie JN,Goodwin AJ,Cook JA,et al.The role of miRNAs in cardiovascular disease risk factors[J].Atherosclerosis,2016,254:271-281.
[4] Li X,Yan X,Wang F,et al.Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signaling pathway in gastric cancer[J].J Cell Mol Med,2019,23(4):2920-2932.
[5] Mao ZJ,Zhang QL,Shang J,et al.Shenfu injection attenuates rat myocardial hypertrophy by up-regulating miR-19a-3p expression[J].Sci Rep,2018,8(1):4660.
[6] 王宏刚,杨 光,姜 乐.Galectin-3抑制剂通过降低Gal-3的表达和心肌纤维化改善大鼠缺血性心力衰竭的机制研究[J].临床和实验医学杂志,2021,20(15):1578-1582.
[7] 张晓雪,郭秋红,李文瑾,等.葶苈生脉方对慢性充血性心力衰竭大鼠NT-proBNP、cTnI及心功能的影响[J].中国中医药现代远程教育,2019,17(18):105-107.
[8] 唐关敏,钱 钢,翟昌林,等.丹参酮ⅡA对缺血性心力衰竭大鼠心肌纤维化的影响[J].医学研究杂志,2018,47(9):105-108.
[9] 赵云丽,袁 勇,马晓莉,等.基于AMPK/SIRT1/PGC-1α信号通路研究香青兰总黄酮对大鼠心肌缺血再灌注损伤的保护机制[J].中国药房,2021,32(3):278-283.
[10] Sui YB,Zhang KK,Ren YK,et al.The role of Nrf2 in astragaloside Ⅳ-mediated antioxidative protection on heart failure[J].Pharm Biol,2020,58(1):1192-1198.
[11] 苏 琳,沈兆峰,张 利,等.益气温阳活血方对充血性心力衰竭合并室性期前收缩患者心功能的影响[J].陕西中医,2021,42(4):442-445.
[12] Liu C,Yang CX,Chen XR,et al.Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats[J].Amino Acids,2018,50(8):1071-1081.
[13] Wang L,Liu C,Chen X,et al.Alamandine attenuates long-term hypertension-induced cardiac fibrosis independent of blood pressure[J].Mol Med Rep,2019,19(6):4553-4560.
[14] Yue Y,Meng K,Pu Y,et al.Transforming growth factor beta(TGF-β)mediates cardiac fibrosis and induces diabetic cardiomyopathy[J].Diabetes Res Clin Pract,2017,133:124-130.
[15] 陈仁山,肖惠珍,刘 宁,等.参芪扶正注射液抑制ERK1/2、GATA4信号通路改善小鼠心力衰竭实验研究[J].陕西中医,2021,43(1):8-12.
[16] Zhang X,Price NL,Fernández-Hernando C.Non-coding RNAs in lipid metabolism[J].Vascul Pharmacol,2019,114:93-102.
[17] Schulte C,Karakas M,Zeller T.MicroRNAs in cardiovascular disease-clinical application[J].Clin Chem Lab Med,2017,55(5):687-704.
[18] Zou M,Wang F,Gao R,et al.Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-βR Ⅱduring TGF-β1-induced fibrogenesis in human cardiac fibroblasts[J].Sci Rep,2016,6:24747.
[19] Chen X,Guo Y,Jia G,et al.Arginine promotes skeletal muscle fiber type transformation from fast-twitch to slow-twitch via Sirt1/AMPK pathway[J].J Nutr Biochem,2018,61:155-162.
[20] 金爱萍,李 蔚,李 冰,等.AMP激活蛋白激酶对慢性心力衰竭进展影响的实验研究[J].陕西医学杂志,2021,50(1):3-6.
[21] Yang X,Liu Q,Li Y,et al.The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signaling pathway[J].Adipocyte,2020,9(1):484-494.
[22] Wen W,Chen X,Huang Z,et al.Resveratrol regulates muscle fiber type conversion via miR-22-3p and AMPK/SIRT1/PGC-1α pathway[J].J Nutr Biochem,2020,77:108297.
[23] 刘 慧,刘 静,刘 聪,等.丹七片对缺血性心脏病大鼠模型能量代谢的调节作用[J].世界中医药,2021,16(15):2322-2327.
[24] Meng H,Wang QY,Li N,et al.Danqi tablet regulates energy metabolism in ischemic heart rat model through AMPK/SIRT1-PGC-1α pathway[J].Chin J Integr Med,2021,27(8):597-603.

相似文献/References:

[1]王玉珏,辛宁宁△.mGluR6对大鼠胚胎神经干细胞生物学功能的影响*[J].陕西医学杂志,2020,49(3):279.
[2]蔡碧莲,文亦磊,罗伟生△.四氯化碳溶液构建肝纤维化大鼠模型研究进展*[J].陕西医学杂志,2020,49(5):639.
[3]刘文强,刘学政,左中夫△.RU486通过Notch1/Hes-1信号通路对糖尿病大鼠视网膜神经节细胞的保护作用及机制研究*[J].陕西医学杂志,2020,49(6):656.[doi:DOI:10.3969/j.issn.10007377.2020.06.004]
 LIU Wenqiang,LIU Xuezheng,ZUO Zhongfu..Protective effect of RU486 on retinal ganglion cells in diabetic rats via Notch1/Hes-1 signaling pathway[J].,2020,49(9):656.[doi:DOI:10.3969/j.issn.10007377.2020.06.004]
[4]蔡碧莲,文亦磊△,罗伟生△.大鼠肝纤维化实验动物模型的构建*[J].陕西医学杂志,2020,49(6):659.[doi:DOI:10.3969/j.issn.10007377.2020.06.005]
[5]朱美霖,白宏英.调控Sonic Hedgehog信号通路对急性脑缺血大鼠血管再生影响的实验研究*[J].陕西医学杂志,2020,49(7):774.[doi:DOI:10.3969/j.issn.10007377.2020.07.002]
 ZHU Meilin,BAI Hongying..Effect of regulating SHH signaling pathway on angiogenesis in rats with acute cerebral ischemia[J].,2020,49(9):774.[doi:DOI:10.3969/j.issn.10007377.2020.07.002]
[6]艾丁丁,罗伟生△,蒋云霞.动物肝纤维化模型建立研究进展*[J].陕西医学杂志,2020,49(7):907.[doi:DOI:10.3969/j.issn.10007377.2020.07.038]
 AI Dingding,LUO Weisheng,JIANG Yunxia..Progress in the establisment of animal liver fibrosis model[J].,2020,49(9):907.[doi:DOI:10.3969/j.issn.10007377.2020.07.038]
[7]朱美霖,白宏英.Purmorphamine对脑缺血再灌注大鼠细胞凋亡影响的实验研究[J].陕西医学杂志,2021,50(1):7.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.002]
 ZHU Meilin,BAI Hongying.Effect of Purmorphamine on apoptosis in rats with cerebral ischemia-reperfusion[J].,2021,50(9):7.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.002]
[8]肖小娟,魏 星,赵莎彤,等.3-甲基腺嘌呤腹腔注射干预大鼠胃窦组织自噬最佳药物剂量与用药时间探讨[J].陕西医学杂志,2021,50(2):131.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.001]
 XIAO Xiaojuan,WEI Xing,ZHAO Shatong,et al.Optimal dose and time of intraperitoneal injection of 3-MA for intervention of gastric antrum autophagy in rats[J].,2021,50(9):131.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.001]
[9]张荣臻,吕 超,石清兰,等.急性肝衰竭大鼠模型构建实验研究[J].陕西医学杂志,2021,50(3):268.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.003]
 ZHANG Rongzhen,LYU Chao,SHI Qinglan,et al.Construction of rat model of acute liver failure[J].,2021,50(9):268.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.003]
[10]唐一萍,冯 俊,马 鹏,等.miRNA-183在噪声性耳聋大鼠耳蜗组织中的表达及临床意义[J].陕西医学杂志,2021,50(5):538.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.006]
 TANG Yiping,FENG Jun,MA Peng,et al.Expression of miRNA-183 in cochlea tissue of noise-deaf rats and its clinical significance[J].,2021,50(9):538.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.006]

备注/Memo

备注/Memo:
基金项目:湖北省自然科学基金资助项目(2022CFC002)
更新日期/Last Update: 2023-09-04